Parteck® SLC Excipient: Adsorb, Stabilize, And Enhance

Drug solubility remains a major challenge in pharmaceutical formulation development, particularly as an increasing number of new drug candidates exhibit poor oral bioavailability due to limited solubility. Addressing this issue, Parteck® SLC emerges as a cutting-edge mesoporous silica excipient specifically designed to enhance the solubility of poorly soluble drugs. Its innovation lies in its unique pore architecture, which enables the adsorption and confinement of drug molecules within nanosized pores. This confinement stabilizes the drugs in their amorphous form—a state known for significantly improved solubility compared to their crystalline counterparts. In addition to its technical advantages, Parteck® SLC is backed by a comprehensive regulatory and quality assurance framework. It complies with major standards, including the United States Pharmacopeia–National Formulary (USP–NF) and the European Pharmacopoeia (Ph. Eur..).

Whether used in standard applications or customized solutions, ensure consistent performance across all stages of your drug development and production with this innovative and dependable solution.